Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
Símbolo de cotizaciónCSBR
Nombre de la empresaChampions Oncology Inc
Fecha de salida a bolsaNov 30, 1988
Director ejecutivoDr. Ronnie Morris, M.D.
Número de empleados213
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 30
DirecciónOne University Plaza,
CiudadHACKENSACK
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal07601
Teléfono12018088400
Sitio Webhttps://championsoncology.com
Símbolo de cotizaciónCSBR
Fecha de salida a bolsaNov 30, 1988
Director ejecutivoDr. Ronnie Morris, M.D.
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos